Amyloidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 5th December 2014
Summary The industry analysis specialist, has released its new report, “Amyloidosis Therapeutics Pipeline Assessment and Market Forecasts to 2019�. The report is an essential source of information and analysis on the global Amyloidosis Therapeutics market. The report identifies the key trends shaping and driving the global Amyloidosis Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Amyloidosis Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-amyloidosis-therapeutics-pipeline-assessment-and-market-forecasts135212 Scope The report provides information on the key drivers and challenges of the Amyloidosis Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Amyloidosis Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Amyloidosis Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Amyloidosis Therapeutics market. - Analysis of key recent licensing and partnership agreements in Amyloidosis Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Amyloidosis Therapeutics market. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Amyloidosis Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Amyloidosis Therapeutics market landscape? – Identify, understand and capitalize.
Other industries we cover:
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table of Content 2 Amyloidosis Therapeutics - Introduction 2.1 Overview 2.2 Types of Amyloidosis 2.3 Pathophysiology of Amyloidosis 2.3.1 Pathophysiology of AL Amyloidosis 2.3.2 Pathophysiology of AA Amyloidosis 2.3.3 Pathophysiology of AF Amyloidosis 2.3.4 Pathophysiology of Aß2M Amyloidosis 2.3.5 Pathophysiology of Senile Amyloidosis 2.4 Epidemiology of Amyloidosis 2.4.1 Epidemiology of AL Amyloidosis 2.4.2 Epidemiology of AA Amyloidosis 2.4.3 Epidemiology of AF Amyloidosis 2.4.4 Epidemiology of Aß2M Amyloidosis 2.4.5 Epidemiology of Senile Amyloidosis 2.5 Etiology of Amyloidosis 2.6 Risk Factors for Development of Amyloidosis 2.7 Signs and Symptoms of Amyloidosis 2.7.1 Kidney (AL, AA) Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.7.2 Heart (AL, AF, Senile) 2.7.3 Liver (AL, AA, AF) 2.7.4 Skin (AL, AA) 2.7.5 Gastrointestinal tract (Common in all Types) 2.7.6 Nervous System (Prominent in AF) 2.7.7 Endocrine 2.7.8 Joints, Bones, and Muscles 2.7.9 Respiratory System 2.7.10 Hematopoietic System 2.7.11 Other 2.8 Diagnosis of Amyloidosis 2.8.1 Physical Examination 2.8.2 Biopsy 2.8.3 Blood Tests 2.8.4 Urine Tests 2.8.5 Imaging Techniques 2.9 Treatment and Management Pattern of Amyloidosis 2.9.1 Treatment of AL Amyloidosis 2.9.2 Treatment of AA Amyloidosis 2.9.3 Treatment of AF Amyloidosis Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.9.4 Treatment of AĂ&#x;2M Amyloidosis 2.9.5 Treatment of Senile Amyloidosis 2.10 Prognosis of Amyloidosis 2.11 GlobalData Pipeline Report Guidance 3 Amyloidosis Therapeutics - Market Characterization 3.1 Amyloidosis Therapeutics Market Size (2006-2011) - Global 3.2 Amyloidosis Therapeutics Market Forecast (2011-2019) - Global 3.3 Amyloidosis Therapeutics Market Size (2006-2011) - The US 3.4 Amyloidosis Therapeutics Market Forecast (2011-2019) - The US 3.5 Amyloidosis Therapeutics Market Size (2006-2011) - France 3.6 Amyloidosis Therapeutics Market Forecast (2011-2019) - France 3.7 Amyloidosis Therapeutics Market Size (2006-2011) - Germany 3.8 Amyloidosis Therapeutics Market Forecast (2011-2019) - Germany 3.9 Amyloidosis Therapeutics Market Size (2006-2011) - Italy 3.10 Amyloidosis Therapeutics Market Forecast (2011-2019) - Italy 3.11 Amyloidosis Therapeutics Market Size (2006-2011) - Spain 3.12 Amyloidosis Therapeutics Market Forecast (2011-2019) - Spain 3.13 Amyloidosis Therapeutics Market Size (2006-2011) - The UK 3.14 Amyloidosis Therapeutics Market Forecast (2011-2019) - The UK 3.15 Amyloidosis Therapeutics Market Size (2006-2011) - Japan Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
3.16 Amyloidosis Therapeutics Market Forecast (2011-2019) - Japan 3.17 Drivers and Barriers for the Amyloidosis Market 3.17.1 Amyloidosis Therapeutics Market Drivers 3.17.2 Amyloidosis Therapeutics Market Barriers 3.18 Opportunity and Unmet Need 4 Amyloidosis Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles for the Major Off-label Marketed Products in the Amyloidosis Therapeutics Market 4.3.1 Chemotherapeutic Agents 4.3.2 Steroids 4.3.3 Immunomodulator 4.3.4 New Agent 4.4 Key Takeaway 5 Amyloidosis Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Amyloidosis Therapeutics - Pipeline Assessment by Phase of Development 5.3.1 Amyloidosis Therapeutics - Recently Approved Drug 5.3.2 Amyloidosis Therapeutics - Phase III Pipeline Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
5.3.3 Amyloidosis Therapeutics - Phase II Pipeline 5.3.4 Amyloidosis Therapeutics - Phase I Pipeline 5.3.5 Amyloidosis Therapeutics - Pre-clinical Pipeline 5.4 Amyloidosis Therapeutics - Pipeline by Mechanism of Action 5.5 Technology Trends Analytical Framework 5.6 Recently Approved Drug 5.6.1 Vyndaqel 5.7 Most Promising Drugs Under Clinical Development 5.7.1 Kiacta 5.8 Key Takeaway 6 Amyloidosis Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 6.2 Clinical Trials by Phase of Clinical Development 6.3 Clinical Trials by Trial Status 6.4 Prominent Sponsors 6.5 Brief Profiles of Top Companies Participating in Therapeutic Clinical Trials 7 Amyloidosis Therapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Future Market Competition Scenario 8 Amyloidosis Therapeutics - Future Players Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
8.1 Introduction 8.2 Company Profiles 8.2.1 Pfizer Inc. 8.2.2 Bellus Health Inc. 9 Amyloidosis Therapeutics - Licensing and Partnership Deals 10 Amyloidosis Therapeutics - Appendix 10.1 Market Definitions 10.2 Acronyms 10.3 Research Methodology 10.3.1 Coverage 10.3.2 Secondary Research 10.3.3 Forecasting 10.3.4 Primary Research 10.3.5 Expert Panel Validation 10.4 Contact Us 10.5 Disclaimer 10.6 Bibliography
List Of Tables Table 1: Amyloid Fibril Protein and Precursor
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 2: Major Organs Involved in Most Common Types of Amyloidosis Table 3: Amyloidosis Therapeutics Market, Global, Revenue ($bn), 2006-2011 Table 4: Amyloidosis Therapeutics, Market, Global, Forecast ($bn), 2011-2019 Table 5: Amyloidosis Therapeutics Market, The US, Revenue ($bn), 2006-2011 Table 6: Amyloidosis Therapeutics Market, The US, Forecasts ($bn), 2011-2019 Table 7: Amyloidosis Therapeutics Market, France, Revenue ($m), 2006-2011 Table 8: Amyloidosis Therapeutics Market, France, Forecasts ($m), 2011-2019 Table 9: Amyloidosis Therapeutics Market, Germany, Revenue ($m), 2006-2011 Table 10: Amyloidosis Therapeutics Market, Germany, Forecasts ($m), 2011-2019 Table 11: Amyloidosis Therapeutics Market, Italy, Revenue ($m), 2006-2011 Table 12: Amyloidosis Therapeutics Market, Italy, Forecasts ($m), 2011-2019 Table 13: Amyloidosis Therapeutics Market, Spain, Revenue ($m), 2006-2011 Table 14: Amyloidosis Therapeutics Market, Spain, Forecasts ($m), 2011-2019 Table 15: Amyloidosis Therapeutics Market, The UK, Revenue ($m), 2006-2011 Table 16: Amyloidosis Therapeutics Market, The UK, Forecasts ($m), 2011-2019 Table 17: Amyloidosis Therapeutics Market, Japan, Revenue ($m), 2006-2011 Table 18: Amyloidosis Therapeutics Market, Japan, Forecasts ($m), 2011-2019 Table 19: Amyloidosis Therapeutics - Recently Approved Drug Table 20: Amyloidosis Therapeutics - Phase III and Approved Pipeline, 2011 Table 21: Amyloidosis Therapeutics - Phase II Pipeline, 2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 22: Amyloidosis Therapeutics - Phase I Pipeline, 2011 Table 23: Amyloidosis Therapeutics - Pre-clinical Pipeline, 2011 Table 24: Amyloidosis Therapeutics Market - Most Promising Drugs Under Clinical Development, 2011 Table 25: Amyloidosis Therapeutics - Clinical Trials by Country, 2011 Table 26: Amyloidosis Therapeutics, Major Markets - Clinical Trials by Phase, 2011 Table 27: Amyloidosis Therapeutics, Major Markets, Clinical Trials by Development Status, 2011 Table 28: Amyloidosis Therapeutics, Major Markets, Prominent Sponsors, 2011 Table 29: Amyloidosis Therapeutics, Major Markets, Clinical Trials of Top Companies by Phase, 2011 Table 30: Pfizer Inc. - Amyloidosis Pipeline, 2011 Table 31: Bellus Health - Amyloidosis Pipeline, 2011 Table 32: Amyloidosis Therapeutics Market - Future Players
List Of Figures Figure 1: Amyloidosis on Face Figure 2: Amyloidosis Therapeutics Market, Global, Revenue ($bn), 2006-2011 Figure 3: Amyloidosis Therapeutics Market, Global, Forecast ($bn), 2011-2019 Figure 4: Amyloidosis Therapeutics Market, The US, Revenue ($bn), 2006-2011 Figure 5: Amyloidosis Therapeutics Market, The US, Forecast ($bn), 2011-2019 Figure 6: Amyloidosis Therapeutics Market, France, Revenue ($m), 2006-2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 7: Amyloidosis Therapeutics Market, France, Forecast ($m), 2011-2019 Figure 8: Amyloidosis Therapeutics Market, Germany, Revenue ($m), 2006-2011 Figure 9: Amyloidosis Therapeutics Market, Germany, Forecast ($m), 2011-2019 Figure 10: Amyloidosis Therapeutics Market, Italy, Revenue ($m), 2006-2011 Figure 11: Amyloidosis Therapeutics Market, Italy, Forecast ($m), 2011-2019 Figure 12: Amyloidosis Therapeutics Market, Spain, Revenue ($m), 2006-2011 Figure 13: Amyloidosis Therapeutics Market, Spain, Forecast ($m), 2011-2019 Figure 14: Amyloidosis Therapeutics Market, The UK, Revenue ($m), 2006-2011 Figure 15: Amyloidosis Therapeutics Market, The UK, Forecast ($m), 2011-2019 Figure 16: Amyloidosis Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 17: Amyloidosis Therapeutics Market, Japan, Forecast ($m), 2011-2019 Figure 18: Opportunity and Unmet Need in the Amyloidosis Therapeutics Market, 2011 Figure 19: Strategic Competitor Assessment, 2011 Figure 20: Amyloidosis Therapeutics Market - Pipeline by Phase of Development, 2011 Figure 21: Amyloidosis Therapeutics - Clinical Pipeline by Mechanism of Action, 2011 Figure 22: Technology Trends Analytics Framework, 2011 Figure 23: Technology Trends Analytics Framework - Description, 2011 Figure 24: Amyloidosis Therapeutics - Clinical Trials by Country, 2011 Figure 25: Amyloidosis Therapeutics, Major Markets - Clinical Trials by Phase, 2011 Figure 26: Amyloidosis Therapeutics, Major Markets, Clinical Trials by Development Status, 2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 27: Amyloidosis Therapeutics, Major Markets, Overall Sponsors, 2011 Figure 28: Amyloidosis Therapeutics, Major Markets, Prominent Sponsors, 2011 Figure 29: Amyloidosis Therapeutics, Major Markets, Clinical Trials of Top Companies by Phase, 2011 Figure 30: Amyloidosis Therapeutics Market, Drivers and Restraints 2011 Figure 31: Implications for Future Market Competition in the Amyloidosis Therapeutics Market, 2011 Figure 32: Amyloidosis Therapeutics Market - Pipeline by Company, 2011 Figure 33: GlobalData Market Forecasting Model
Report Price:
Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Related Reports: Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018 Cushings Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Pompe Disease (GAA Deficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Liposarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Amyloidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
http://www.jsbmarketresearch.com/healthcare-medical/r-amyloidosistherapeutics-pipeline-assessment-and-market-forecasts-135212
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/